Pacira BioSciences, Inc.

PCRX

NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

Tampa, FL, US788 employeespacira.com

$22.75

-0.04(-0.20%)

Mkt Cap $979M

$19.16

$27.22

52-Week Range

At A Glance

Pacira BioSciences, Inc.

Revenue is primarily driven by EXPAREL (79.1%) and ZILRETTA (16.4%).

Most recently: . Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January (2026-01-28).

$979M

Market Cap

$735M

Revenue

$7M

Net Income

Employees788

Fundamentals

How The Business Makes Money

Revenue by Segment

EXPAREL79.1%($1.7B)

ZILRETTA16.4%($346M)

Iovera3.2%($67M)

Bupivacaine Liposome Injectable Suspension0.8%($18M)

Royalty0.5%($10M)

Activity

What Changed Recently

Management Change

Jan 27, 2026

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January

Financial Results

Feb 25, 2026

of Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exc

Financial Results

Jan 7, 2026

and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),

Peer Companies

Company	Price	Change	Market Cap	P/E
KODKodiak Sciences Inc.	$40.55	-5.28%	$2.1B	-5.4
ANABAnaptysBio, Inc.	$57.98	+2.20%	$1.7B	-131.7
MNMDMind Medicine (MindMed) I...	$20.65	+0.24%	$1.6B	-8.8
OCSOculis Holding AG	$26.48	-2.03%	$1.5B	-11.0
TNDMTandem Diabetes Care, Inc...	$18.57	-1.30%	$1.3B	-8.3
CRONCronos Group Inc.	$2.54	+1.00%	$975M	-102.5
XNCRXencor, Inc.	$12.79	+2.11%	$938M	-9.7
URGNUroGen Pharma Ltd.	$18.84	-0.53%	$917M	-5.5

Analyst View

Company Profile

CIK0001396814

ISINUS6951271005

CUSIP695127100

Phone813 553 6680

Address5401 West Kennedy Boulevard, Tampa, FL, 33609, US

SEC EDGAR